Cargando…
Diuretics: again the first step in the treatment of most patients with hypertension
The results and interpretations of the most recent controlled clinical trials on antihypertensive drugs have fuelled the debate about the drug that should be used to begin treatment for hypertension. Every comparison of diuretics with other drugs has shown that the benefits of diuretics are equivale...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59527/ https://www.ncbi.nlm.nih.gov/pubmed/11806804 http://dx.doi.org/10.1186/cvm-2-5-244 |
_version_ | 1782120065153368064 |
---|---|
author | Fuchs, Flávio Danni |
author_facet | Fuchs, Flávio Danni |
author_sort | Fuchs, Flávio Danni |
collection | PubMed |
description | The results and interpretations of the most recent controlled clinical trials on antihypertensive drugs have fuelled the debate about the drug that should be used to begin treatment for hypertension. Every comparison of diuretics with other drugs has shown that the benefits of diuretics are equivalent to, or better than, other options. These findings, together with other practical reasons, such as left ventricular mass reducing effect, easy administration, few side effects and low cost, suggest that diuretics should regain their primacy as the first step in drug management of hypertension. |
format | Text |
id | pubmed-59527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-595272001-11-06 Diuretics: again the first step in the treatment of most patients with hypertension Fuchs, Flávio Danni Curr Control Trials Cardiovasc Med Review The results and interpretations of the most recent controlled clinical trials on antihypertensive drugs have fuelled the debate about the drug that should be used to begin treatment for hypertension. Every comparison of diuretics with other drugs has shown that the benefits of diuretics are equivalent to, or better than, other options. These findings, together with other practical reasons, such as left ventricular mass reducing effect, easy administration, few side effects and low cost, suggest that diuretics should regain their primacy as the first step in drug management of hypertension. BioMed Central 2001 2001-09-25 /pmc/articles/PMC59527/ /pubmed/11806804 http://dx.doi.org/10.1186/cvm-2-5-244 Text en Copyright © 2001 BioMed Central Ltd |
spellingShingle | Review Fuchs, Flávio Danni Diuretics: again the first step in the treatment of most patients with hypertension |
title | Diuretics: again the first step in the treatment of most patients with hypertension |
title_full | Diuretics: again the first step in the treatment of most patients with hypertension |
title_fullStr | Diuretics: again the first step in the treatment of most patients with hypertension |
title_full_unstemmed | Diuretics: again the first step in the treatment of most patients with hypertension |
title_short | Diuretics: again the first step in the treatment of most patients with hypertension |
title_sort | diuretics: again the first step in the treatment of most patients with hypertension |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59527/ https://www.ncbi.nlm.nih.gov/pubmed/11806804 http://dx.doi.org/10.1186/cvm-2-5-244 |
work_keys_str_mv | AT fuchsflaviodanni diureticsagainthefirststepinthetreatmentofmostpatientswithhypertension |